We send periodic emails with analyses of biotech startups and scientific papers. You can find the analyses we've done thus far below (we started doing this in October 2023).
We use AI tools to write 95%+ of the text in these reports, with some light manual editing and a bit of human commentary here or there.
This is not investment advice. AI does the research and writes the text. We proofread and fact-check each article, though we can't guarantee the analysis is 100% accurate. We are shooting for comprehensive yet concise first-pass review of companies.
Analyzed on March 28, 2024
Analyzed on March 28, 2024
Analyzed on March 1, 2024
Analyzed on March 1, 2024
Analyzed on March 1, 2024
Analyzed on March 1, 2024
Analyzed on March 1, 2024
Analyzed on February 22, 2024
Analyzed on February 14, 2024
Analyzed on February 7, 2024
Analyzed on January 8, 2024
Analyzed on November 14, 2023
Analyzed on November 14, 2023
Analyzed on November 6, 2023
Analyzed on October 31, 2023
Analyzed on October 25, 2023
Analyzed on October 17, 2023
Analyzed on October 17, 2023